The objective of this study was to compare resource utilisation and associated healthcare costs between the OPD patients treated with buprenorphine/naloxone combination and OPD patients without pharmacological treatment from the German healthcare perspective. (Source: Value in Health)
Cost burden analysis of relapse in prescription Opioid Drug dependent Patients treated with Buprenorphine/Naloxone and Patients without Pharmacological treatment
Previous post: Factors associated with willingness to take extended release naltrexone among injection drug users.
Next post: Science Be Damned: Americans Prefer Broken Method Of Heroin Treatment, Survey Finds
